Jump to navigation
Donate
Driving Change in 2023: Our year in review
Opill launches as the first OTC birth control pill in the United States!
Misoprostol-only resource hub: Highlighting its safety & effectiveness
Announcing the Support Unseen Podcast launch
Announcing the launch of Ibis's Africa Region Strategy for 2022-2025
A just, inclusive world where we all exercise our human right to a pleasurable, safe, and healthy sexual and reproductive life.
#IbisDrivesChange
Telehealth enables safe medication abortion in shifting health and legal contexts
Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States
Experiences self-managing an abortion using medication in India (community factsheet in Tamil)
Ibis responds to Supreme Court oral arguments in FDA v. Alliance for Hippocratic Medicine
The unfinished revolution: A global perspective on abortion and reproductive justice
No-prescription birth control pills soon available in US pharmacies